13F-HR: NVIDIA Corp Discloses Q1 2024 Holdings in Form 13F Filing

NVIDIA Corp's latest 13F filing reveals its investment portfolio as of March 31, 2024, with significant holdings in ARM Holdings, Recursion Pharmaceuticals, and other tech companies.

Summary

• NVIDIA Corp filed its Form 13F for the quarter ended March 31, 2024, disclosing its holdings.
• The total value of reported holdings is approximately $332.7 million.
• The filing lists four holdings, including ARM Holdings PLC, Nano X Imaging Ltd, Recursion Pharmaceuticals, and SoundHound AI Inc.
• The largest holding is in ARM Holdings PLC, valued at approximately $245.1 million.
• Recursion Pharmaceuticals is the second largest holding, valued at approximately $76.8 million.
• The holdings in Nano X Imaging Ltd and SoundHound AI Inc are valued at approximately $0.6 million and $10.2 million respectively.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of holdings, which is generally neutral. The large investment in ARM Holdings is a positive sign, but the overall sentiment is balanced.

Positives

• The filing provides transparency into NVIDIA's investment portfolio.
• The large investment in ARM Holdings PLC suggests a strong belief in its future prospects.
• The investment in Recursion Pharmaceuticals indicates an interest in the biotechnology sector.

Risks

• The value of these holdings is subject to market fluctuations.
• The performance of these investments will impact NVIDIA's overall financial results.

Industry Context

This filing reflects NVIDIA's investment strategy in technology and biotechnology sectors, aligning with its broader focus on innovation and growth. The investments in AI-related companies like SoundHound AI and Recursion Pharmaceuticals are consistent with industry trends.

Comparison to Industry Standards

• NVIDIA's investment in ARM Holdings is a significant move, comparable to other tech giants investing in semiconductor design companies.
• The investment in Recursion Pharmaceuticals is similar to other tech companies diversifying into the biotech sector, such as Google's investment in Calico.
• The size of the holdings is consistent with other large institutional investors, but the specific companies chosen reflect NVIDIA's strategic focus.

Stakeholder Impact

• Shareholders can gain insights into NVIDIA's investment strategy.
• The investments may impact the share prices of the companies NVIDIA has invested in.

Key Dates

Keywords

NVIDIA, Form 13F, Investment Portfolio, ARM Holdings, Recursion Pharmaceuticals, Nano X Imaging, SoundHound AI, Institutional Investment